176 related articles for article (PubMed ID: 29290969)
1. Low plasma levels of miR-101 are associated with tumor progression in gastric cancer.
Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Okamoto K; Fujiwara H; Otsuji E
Oncotarget; 2017 Dec; 8(63):106538-106550. PubMed ID: 29290969
[TBL] [Abstract][Full Text] [Related]
2. Depletion of tumor suppressor miRNA-148a in plasma relates to tumor progression and poor outcomes in gastric cancer.
Komatsu S; Imamura T; Kiuchi J; Takashima Y; Kamiya H; Ohashi T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Otsuji E
Am J Cancer Res; 2021; 11(12):6133-6146. PubMed ID: 35018247
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.
Cao Y; Tan S; Tu Y; Zhang G; Liu Y; Li D; Xu S; Le Z; Xiong J; Zou W; Gong P; Li Z; Jie Z
Oncol Lett; 2018 Apr; 15(4):5119-5130. PubMed ID: 29552146
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑153 may act as a potential biomarker and prognostic indicator of patients with gastric cancer.
Li T; Guo D; Xu X; Liu P; Wang P; Zhu Y; Lin L; Qu Y; Liu F; Chu Y; Gao X
Oncol Lett; 2023 Jul; 26(1):278. PubMed ID: 37274464
[TBL] [Abstract][Full Text] [Related]
5. miR-1286, a Tumor Suppressor of Gastric Cancer, Serves as a Promising Biomarker for Screening Gastric Cancer from Gastritis.
Tian M; Jiang M; Bi Y; Wang B
Biochem Genet; 2024 Jan; ():. PubMed ID: 38217797
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expression.
Li D; Li Z; Xiong J; Gong B; Zhang G; Cao C; Jie Z; Liu Y; Cao Y; Yan Y; Xiong H; Qiu L; Yang M; Chen H; Jiang S; Yang X; Chen H
Am J Cancer Res; 2015; 5(10):2980-97. PubMed ID: 26693054
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer.
Shi J; Chen P; Sun J; Song Y; Ma B; Gao P; Chen X; Wang Z
Oncol Lett; 2017 May; 13(5):3739-3745. PubMed ID: 28521475
[TBL] [Abstract][Full Text] [Related]
9. The downregulation of miR-519a predicts poor prognosis and contributes to tumor progression in gastric cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Int J Clin Exp Pathol; 2019; 12(7):2496-2505. PubMed ID: 31934076
[TBL] [Abstract][Full Text] [Related]
10. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer.
Soeda N; Iinuma H; Suzuki Y; Tsukahara D; Midorikawa H; Igarashi Y; Kumata Y; Horikawa M; Kiyokawa T; Fukagawa T; Fukushima R
Oncol Lett; 2019 Nov; 18(5):4467-4480. PubMed ID: 31611956
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer.
Zhang JK; Li YS; Zhang CD; Dai DQ
Cancer Cell Int; 2017; 17():28. PubMed ID: 28239297
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
[TBL] [Abstract][Full Text] [Related]
13. Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer.
Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Konishi H; Shiozaki A; Morimura R; Ikoma H; Ochiai T; Okamoto K; Taniguchi H; Otsuji E
Sci Rep; 2017 Jul; 7(1):5708. PubMed ID: 28720759
[TBL] [Abstract][Full Text] [Related]
14. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
Yue CF; Li LS; Ai L; Deng JK; Guo YM
Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
16. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
[TBL] [Abstract][Full Text] [Related]
18. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
19. miR-613 inhibits gastric cancer progression through repressing brain derived neurotrophic factor.
Ding D; Hou R; Gao Y; Feng Y
Exp Ther Med; 2018 Feb; 15(2):1735-1741. PubMed ID: 29434759
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14.
Liu YP; Sun XH; Cao XL; Jiang WW; Wang XX; Zhang YF; Wang JL
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1759-1767. PubMed ID: 28485805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
